Glaucoma Center of San Francisco, Glaucoma Research and Education Group, San Francisco, California.
Department of Ophthalmology, University of Washington, Seattle, Washington.
Ophthalmology. 2018 Jul;125(7):1110-1120. doi: 10.1016/j.ophtha.2018.01.015. Epub 2018 Mar 2.
To examine the efficacy and complications of laser peripheral iridotomy (LPI) in subjects with primary angle closure (PAC).
Literature searches in the PubMed and Cochrane databases were last conducted in August 2017 and yielded 300 unique citations. Of these, 36 met the inclusion criteria and were rated according to the strength of evidence; 6 articles were rated level I, 11 articles were rated level II, and 19 articles were rated level III.
Reported outcomes were change in angle width, effect on intraocular pressure (IOP) control, disease progression, and complications. Most of the studies (29/36, 81%) included only Asian subjects. Angle width (measured by gonioscopy, ultrasound biomicroscopy, and anterior segment OCT) increased after LPI in all stages of angle closure. Gonioscopically defined persistent angle closure after LPI was reported in 2% to 57% of eyes across the disease spectrum. Baseline factors associated with persistent angle closure included narrower angle and parameters representing nonpupillary block mechanisms of angle closure, such as a thick iris, an anteriorly positioned ciliary body, or a greater lens vault. After LPI, further treatment to control IOP was reported in 0%-8% of PAC suspect (PACS), 42% to 67% of PAC, 21% to 47% of acute PAC (APAC), and 83%-100% of PAC glaucoma (PACG) eyes. Progression to PACG ranged from 0% to 0.3% per year in PACS and 0% to 4% per year in PAC. Complications after LPI included IOP spike (8-17 mmHg increase from baseline in 6%-10%), dysphotopsia (2%-11%), anterior chamber bleeding (30%-41%), and cataract progression (23%-39%).
Laser peripheral iridotomy increases angle width in all stages of primary angle closure and has a good safety profile. Most PACS eyes do not receive further intervention, whereas many PAC and APAC eyes, and most PACG eyes, receive further treatment. Progression to PACG is uncommon in PACS and PAC. There are limited data on the comparative efficacy of LPI versus other treatments for the various stages of angle closure; 1 randomized controlled trial each demonstrated superiority of cataract surgery over LPI in APAC and of clear lens extraction over LPI in PACG or PAC with IOP above 30 mmHg.
观察激光周边虹膜切开术(LPI)治疗原发性闭角型青光眼(PAC)的疗效和并发症。
对 2017 年 8 月前在 PubMed 和 Cochrane 数据库中进行的文献检索进行了评估,共获得 300 篇独特的参考文献。其中,36 篇符合纳入标准,并根据证据强度进行了评估;6 篇为 I 级,11 篇为 II 级,19 篇为 III 级。
报告的结果为眼内压(IOP)控制、疾病进展和并发症的角度宽度变化。大多数研究(29/36,81%)仅纳入亚洲人群。在闭角型青光眼的各个阶段,LPI 后,角宽度(通过房角镜、超声生物显微镜和眼前节 OCT 测量)均增加。在疾病谱的各个阶段,LPI 后仍有 2%至 57%的眼存在房角镜定义的持续性闭角。与持续性闭角相关的基线因素包括更窄的角度和代表虹膜非瞳孔阻滞机制的参数,如虹膜增厚、睫状体靠前位置或晶状体拱高更大。LPI 后,为控制 IOP 进一步治疗的报告率为 PAC 可疑(PACS)眼 0%至 8%,PAC 眼 42%至 67%,急性闭角型青光眼(APAC)眼 21%至 47%,PAC 青光眼(PACG)眼 83%至 100%。PACS 中每年进展为 PACG 的比例为 0.3%,PAC 中每年进展为 0.3%至 4%。LPI 后出现的并发症包括眼压升高(比基线升高 8-17mmHg,发生率为 6%-10%)、光幻视(2%-11%)、前房出血(30%-41%)和白内障进展(23%-39%)。
激光周边虹膜切开术可增加原发性闭角型青光眼各个阶段的角度宽度,具有良好的安全性。大多数 PACS 眼不需要进一步干预,而许多 PAC 和 APAC 眼,以及大多数 PACG 眼,需要进一步治疗。PACS 中进展为 PACG 的情况并不常见。关于 LPI 与各种阶段闭角型青光眼的其他治疗方法的比较疗效的数据有限;1 项随机对照试验均表明,APAC 中白内障手术优于 LPI,PACG 或 IOP 高于 30mmHg 的 PAC 中晶状体超声乳化术优于 LPI。